Cognitive impairment in schizophrenia involves a broad array of nonsocial and social
cognitive domains. It is a core feature of the illness, and one with substantial implications for …

Cognitive impairment is a core feature of schizophrenia and a major contributor to poor
functional outcomes. Methods for assessment of cognitive dysfunction in schizophrenia are …

Objective: Many psychotropic medications used to treat schizophrenia have significant
anticholinergic properties, which are linked to cognitive impairment and dementia risk in …

The self-disorder model offers a unifying way of conceptualizing schizophrenia's highly
diverse symptoms (positive, negative, disorganized), of capturing their distinctive …

Current clinical phenomenological diagnosis in psychiatry neither captures biologically
homologous disease entities nor allows for individualized treatment prescriptions based on …

Background Abnormalities in cortical excitation and inhibition (E/I) balance are thought to
underlie sensory and information processing deficits in schizophrenia. Deficits in early …

We review the changing conceptions of schizophrenia over the past 50 years as it became
understood as a disorder of brain function and structure in which neurocognitive dysfunction …

Eye movements are indispensable for the collection of visual information in everyday life.
Many findings regarding the neural basis of eye movements have been accumulated from …

Cognitive impairment is a hallmark of schizophrenia and a robust predictor of functional
outcomes. Impairments are found in all phases of the illness and are only moderately …

Emerging research on neuroplasticity processes in psychosis spectrum illnesses—from the
synaptic to the macrocircuit levels—fill key gaps in our models of pathophysiology and open …